Determinants of Inhibition of Transiently Expressed Voltage-gated Calcium Channels by ω-Conotoxins GVIA and MVIIA

This publication has 26 references indexed in Scilit:

• Actions of intrathecal ω-conotoxins CVID, GVIA, MVIIA, and morphine in acute and neuropathic pain in the rat
  European Journal of Pharmacology, 2002
• Inhibition of transiently expressed low- and high-voltage-activated calcium channels by trivalent metal cations.
  The Journal of Membrane Biology, 2002
• Intractable Delirium Associated With Ziconotide Successfully Treated With Electroconvulsive Therapy
  Psychosomatics, 2002
• Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel
  The EMBO Journal, 2001
• Residue Gly1326 of the N-type Calcium Channel α1B Subunit Controls Reversibility of ω-Conotoxin GVIA and MVIIA Block
  Journal of Biological Chemistry, 2001
• An evaluation of intrathecal ziconotide for the treatment of chronic pain
  Expert Opinion on Investigational Drugs, 2000
• Irreversible and reversible blockade of IMR32 calcium channel currents by synthetic MVIIA and iodinated MVIIC ?-conopeptides
  Pflügers Archiv - European Journal of Physiology, 1995
• Structural determinants of the blockade of N-type calcium channels by a peptide neurotoxin
  Nature, 1994
• Calcium Channel Subtypes in Rat Brain: Biochemical Characterization of the High-Affinity Receptors for ω-Conopeptides SNX-230 (Synthetic MVIIC), SNX-183 (SVIB), and SNX-111 (MVIIA)
  Molecular and Cellular Neuroscience, 1994
• CALCIUM CHANNEL DIVERSITY AND NEUROTRANSMITTER RELEASE: The ω-Conotoxins and ω-Agatoxins
  Annual Review of Biochemistry, 1994